Filing Flows › Comparisons › ZVRA vs LFVN
Zevra Therapeutics vs Lifevantage: ZVRA and LFVN compared
Zevra Therapeutics is the larger company: $37.8M of revenue in its latest quarter (Q3 2026) against $37.1M for Lifevantage (Q3 2026). Zevra Therapeutics is growing faster (+45% against -22% a year earlier). Zevra Therapeutics is more profitable, with an operating margin of 30.7% against -0.4%.
Where the money goes: ZVRA and LFVN
Zevra Therapeutics (ZVRA) · Q3 2026
Zevra Therapeutics, Q3 2026: revenue $37.8M (+45% year over year), operating margin 30.7%, net earnings $19.2M, operating cash flow $10.0M. The chart follows the revenue to costs, profit and cash.
Lifevantage (LFVN) · Q3 2026
Lifevantage, Q3 2026: revenue $37.1M (-22% year over year), operating margin -0.4%, net loss $196K, operating cash flow $533K. The chart follows the revenue to costs, profit and cash.
| Zevra Therapeutics (ZVRA) | Lifevantage (LFVN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $37.8M | $37.1M |
| Revenue growth, Y/Y | +45% | -22% |
| Operating margin | 30.7% | -0.4% |
| Net earnings | $19.2M | −$196K |
| Net margin | 50.9% | -0.5% |
| Operating cash flow | $10.0M | $533K |
| Free cash flow | $9.8M | — |
| Market value | $636M | — |
| P/E | 8.5× | — |
| Analysts’ mean target | $25.25 | — |
Where the revenue comes from
Lifevantage
- Protandim: $18.0M (48%)
- True Science Product Line: $7.6M (20%)
- Life Vantage Product Line: $4.8M (13%)
- AXIO Product Line: $2.9M (8%)
Questions
Which is bigger, Zevra Therapeutics or Lifevantage?
Zevra Therapeutics is the larger company: $37.8M of revenue in its latest quarter (Q3 2026) against $37.1M for Lifevantage (Q3 2026).
Is Zevra Therapeutics or Lifevantage growing faster?
Zevra Therapeutics is growing faster (+45% against -22% a year earlier).
Which is more profitable, Zevra Therapeutics or Lifevantage?
Zevra Therapeutics is more profitable, with an operating margin of 30.7% against -0.4%.
More: Zevra Therapeutics earnings · how Zevra Therapeutics makes money · Lifevantage earnings · how Lifevantage makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.